Axis-Shield overcomes hitches and stays in black for 2006
This article was originally published in Clinica
Executive Summary
Anglo-Norwegian in vitro diagnostics specialist Axis-Shield has succeeded in maintaining profitability for the second year running, despite suffering a couple of setbacks during 2006 that affected the launch of its new Afinion system and sales of its homocysteine tests.